Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Selvaraj EA. et al, (2019), World Journal of Gastroenterology, 25, 644 - 658
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
de Vries EM. et al, (2018), Gut, 67, 1864 - 1869
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.
Muir AJ. et al, (2018), Hepatology
Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis.
Chapman RW., (2018), Br J Hosp Med (Lond), 79, 460 - 464
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.
Kowdley KV. et al, (2018), Hepatology, 67, 1890 - 1902
Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?
Chapman RW., (2018), Aliment Pharmacol Ther, 47, 1321 - 1322
INTERNATIONAL EXPERIENCE OF VEDOLIZUMAB IN PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
Williamson KD. et al, (2018), GASTROENTEROLOGY, 154, S1097 - S1097
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.
de Graaf KL. et al, (2018), Hepatol Commun, 2, 492 - 503
A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC)
Muir AJ. et al, (2017), HEPATOLOGY, 66, 81A - 81A
Quantification of biliary tree volume in patients with PSC using three dimensional (3D) reconstruction of magnetic resonance cholangiopancreatography (MRCP): Clinical associations and prognostic significance
Tempany-Afdhal C. et al, (2017), HEPATOLOGY, 66, 164A - 165A
Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial
Muir AJ. et al, (2017), HEPATOLOGY, 66, 156A - 156A
Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease
Gwela A. et al, (2017), Journal of Crohn's and Colitis, 11, 1124 - 1134
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Alberts R. et al, (2017), Gut, 67, 1517 - 1524
Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?
Chapman RW. and Williamson KD., (2017), Current Hepatology Reports, 16, 124 - 129
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ. et al, (2017), Gastroenterology, 152, 1975 - 1984.e8
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Fickert P. et al, (2017), Journal of hepatology, 67, 549 - 558
Sa1206 Use of Chromoendoscopy Versus White Light Endoscopy for Colorectal Cancer Surveillance in Inflammatory Bowel Disease Patients With Primary Sclerosing Cholangitis Cohort: A Six Year Experience
Hartery K. et al, (2017), Gastrointestinal Endoscopy, 85, AB200 - AB200
Clinical and Translational Outcomes in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease Receiving Vedolizumab
Williamson KD. et al, (2017), Gastroenterology, 152, S1186 - S1187